First Citizens Financial Corp’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.21K | Hold |
35,100
| – | – | ﹤0.01% | 139 |
|
|
2026
Q1 | $2.46K | Hold |
35,100
| – | – | ﹤0.01% | 135 |
|
|
2025
Q4 | $1.41K | Hold |
35,100
| – | – | ﹤0.01% | 127 |
|
|
2025
Q3 | $2.06K | Hold |
35,100
| – | – | ﹤0.01% | 136 |
|
|
2025
Q2 | $4.13K | Hold |
35,100
| – | – | ﹤0.01% | 124 |
|
|
2025
Q1 | $5.09K | Hold |
35,100
| – | – | ﹤0.01% | 121 |
|
|
2024
Q4 | $3.51K | Hold |
35,100
| – | – | ﹤0.01% | 121 |
|
|
2024
Q3 | $4.21K | Hold |
35,100
| – | – | ﹤0.01% | 121 |
|
|
2024
Q2 | $6.67K | Hold |
35,100
| – | – | ﹤0.01% | 114 |
|
|
2024
Q1 | $14K | Hold |
35,100
| – | – | 0.01% | 113 |
|
|
2023
Q4 | $20.7K | Hold |
35,100
| – | – | 0.01% | 111 |
|
|
2023
Q3 | $18.4K | Hold |
35,100
| – | – | 0.01% | 111 |
|
|
2023
Q2 | $6.67K | Buy |
+35,100
| New | +$13.8K | ﹤0.01% | 112 |
|
|
2022
Q4 | $11K | Hold |
35,100
| – | – | 0.01% | 100 |
|
|
2022
Q3 | $15K | Hold |
35,100
| – | – | 0.01% | 92 |
|
|
2022
Q2 | $15K | Hold |
35,100
| – | – | 0.01% | 100 |
|
|
2022
Q1 | $44K | Hold |
35,100
| – | – | 0.03% | 103 |
|
|
2021
Q4 | $46K | Hold |
35,100
| – | – | 0.03% | 105 |
|
|
2021
Q3 | $72K | Hold |
35,100
| – | – | 0.06% | 100 |
|
|
2021
Q2 | $55K | Hold |
35,100
| – | – | 0.04% | 114 |
|
|
2021
Q1 | $78K | Hold |
35,100
| – | – | 0.06% | 106 |
|
|
2020
Q4 | $89K | Hold |
35,100
| – | – | 0.08% | 105 |
|
|
2020
Q3 | $86K | Hold |
35,100
| – | – | 0.09% | 101 |
|
|
2020
Q2 | $125K | Hold |
35,100
| – | – | 0.13% | 95 |
|
|
2020
Q1 | $82K | Buy |
+35,100
| New | +$98.5K | 0.11% | 79 |
|
First Citizens Financial Corp's NYMX Position: Q2 2026 in Review
First Citizens Financial Corp held its Nymox Pharmaceutical Corp (NYMX) position steady in Q2 2026 at 35,100 shares worth $4.21K. The position accounts for ﹤0.01% of the portfolio, ranked #139.
First Citizens Financial Corp first reported a position in NYMX in Q1 2020 and has held it in 25 quarters since. The position peaked at $125K in Q2 2020. 1 fund tracked by Wall St. Rank holds NYMX as of Q2 2026.
- First Citizens Financial Corp held 35,100 shares of Nymox Pharmaceutical Corp worth $4.21K as of Q2 2026.
- First Citizens Financial Corp left its Nymox Pharmaceutical Corp share count unchanged in Q2 2026.
- Nymox Pharmaceutical Corp made up ﹤0.01% of First Citizens Financial Corp's portfolio in Q2 2026, its #139 holding.
- First Citizens Financial Corp first reported a position in Nymox Pharmaceutical Corp in Q1 2020 and has held it in 25 quarters since.
- First Citizens Financial Corp's Nymox Pharmaceutical Corp position peaked at $125K in Q2 2020.
- 1 fund tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2026.
Based on First Citizens Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.